Search for a report

Reports

  • You are here:
  • Home
  • Downloads
  • GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

In terms of revenue, the global contrast enhanced ultrasound market was valued at $1698.22 million in 2021, and is expected to reach $2689.20 million by 2030, growing at a CAGR of 5.25% during the forecast period, 2022-2030.

GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET FORECAST 2022-2030

Global Contrast Enhanced Ultrasound Market by Product (Equipment, Contrast Agent) Market by Type (Non-targeted, Targeted) Market by End-user (Hospitals, Clinics, Ambulatory Diagnostic Centers) by Geography

Request free sample

In terms of revenue, the global contrast enhanced ultrasound market was valued at $1698.22 million in 2021, and is expected to reach $2689.20 million by 2030, growing at a CAGR of 5.25% during the forecast period, 2022-2030.

Contrast enhanced ultrasound (CEUS) is a diagnostic technique that uses ultrasound contrast agents and improves the characterization and visualization of anatomic structures and lesions. Although it can be administered intraoperatively, the transcutaneous application is the most common method. Ultrasound contrast agents in the form of microbubbles consist of gas bubbles equilibrated by a shell and are up to 1 to 10 microns in size, allowing both microvasculature and macrovasculature visualization.

Contrast Enhanced Ultrasounds Market

Read our latest blog on the Contrast Enhanced Ultrasound Market

The most widely used ones are perfluorobutane along with phospholipid shell like Sonazoid, perfluoropropane and octafluoropropane along with outer lipid shell (Definity®), and sulfur hexafluoride along with phospholipid shell (SonoVue/Lumason). The Food and Drug Administration (FDA) recently authorized the contrast agent Lumason (sulfur hexafluoride lipid microspheres) for imaging the liver in adult and pediatric patients. Only a minuscule amount of contrast agent (usually 1 to 2 mL) is needed since ultrasonography contrast agents stay in the vascular space.

Key growth drivers of the global contrast enhanced ultrasound market are:

  • Surging prevalence of chronic diseases
  • Health practitioners prefer contrast enhanced ultrasound imaging
    • Contrast enhanced ultrasonography (CEUS) is a radiation-free imaging modality suitable for pediatric patients, delivers informative results, has a high safety level, and is portable and less expensive than alternative methods.
    • In order to give patients more access to affordable, secure, and reliable diagnostic imaging, ultrasound experts have also pushed the medical community to adopt the use of ultrasonic contrast agents (UCAs).
    • A 2019 study by the International Contrast Ultrasound Society (ICUS) found that UCAs prevented 32.8% of patients from requiring additional redundant downstream testing, saving $122 per patient.
  • Technological advancements in diagnosis

Key market growth restraining factors are:

  • Non-uniformity of contrast agents
  • Difficulty in adoption in the current healthcare system
    • Despite the clinical benefits of contrast enhanced ultrasonography, adoption in present healthcare systems worldwide is hindered by a number of factors.
    • Few doctors have experience in noncardiac contrast enhanced ultrasonography because it is primarily used for cardiovascular diagnostics. However, medical organizations and professional communities continue to offer more training possibilities.
    • Another impediment is the consistent terminologies and classification criteria.

Global Contrast Enhanced Ultrasound Market | Top Trends

  • New, cutting-edge developments in the contrast enhanced ultrasound market encompass the creation of novel pulse sequences and image processing methods, developing devices, and creating remote monitoring for ultrasonic therapies.
  • In addition to detecting active bleeding sites and hematomas in patients with abdominal trauma, contrast enhanced ultrasounds also prevent exposure to ionizing radiation and allow monitoring of patients receiving conservative treatment.
  • Targeted drug delivery into artery walls and thrombi, as well as its use for targeted drug therapy in the delivery of chemotherapeutic drugs, are some of the therapeutic applications of contrast enhanced ultrasound imaging currently being researched.

To know more about this report, request a free sample copy

Market Segmentation – Product, Type, and End-User –

Market by Product:

  • Equipment
  • Contrast Agent
    • Contrast agent is the fastest-growing product in the market. Contrast agents find application in clinical and scientific activities and are commonly used for left ventricular opacification and endocardial border definition during echocardiography.
    • Additionally, contrast agents are being utilized more frequently to distinguish between liver lesions and examine the breast’s microvasculature. Also, by preventing unnecessary surgeries and biopsies, the use of contrast agents to distinguish between benign and malignant liver tumors eventually reduces costs.
    • Besides, the introduction of second-generation contrast agents with increased stability, contrast, and biocompatibility will propel the growth of the studied market.

Market by Type:

  • Non-Targeted
    • Non-targeted is the highest revenue-generating type. It is a major constituent of commercially available products. It includes gadolinium (Gd) agents that are both extracellular and non-targeted.
    • It is commonly employed in organ perfusion, and to evaluate the vascularity of a target lesion (liver or kidney) commonly seen during liver cirrhosis and cancer illnesses.
    • Since excessive alcohol consumption leads to liver cirrhosis, the demand for non-targeted ultrasound contrast agents is predicted to increase with the changing demographics of alcohol consumption globally.
  • Targeted

Market by End-User:

  • Hospitals
  • Clinics
  • Ambulatory Diagnostic Centers

 

Geographical Study based on Four Major Regions:

  • North America: The United States and Canada
  • Europe: The United Kingdom, Germany, France, Italy, Spain, Nordic Countries, and Rest of Europe
  • Asia-Pacific: China, Japan, India, South Korea, Indonesia, Singapore, Taiwan, Australia & New Zealand, and Rest of Asia-Pacific
    • The Asia-Pacific is expected to be the most dynamic regional market owing to rapid improvement in healthcare expenditure, especially in countries such as India and China, and the macroeconomic socioeconomic factors such as the government’s regulatory role, income inequality, urbanization, and globalization.
    • A lack of well-organized compensation policies and the region’s growing price-sensitive populations are anticipated to increase the demand for low-cost procedures like contrast enhanced ultrasound imaging. However, the lack of skilled labor in remote areas challenges market growth.
    • China had the highest market share of 27.97% in 2021, attributed to the development of the private healthcare sector and shifting demographics and illness trends. Moreover, COVID-19 has been significant in enabling the incorporation of contrast enhanced ultrasound technology in point-of-care diagnostics.
    • Furthermore, in India, domestic healthcare providers are collaborating with international market players to penetrate large markets, and carry out marketing, distribution, and production activities accordingly.
  • Rest of World: Latin America, Middle East & Africa

The major players in the global contrast enhanced ultrasound market are:

  • GE Healthcare
  • Siemens Healthineers AG
  • Acusphere Inc
  • Koninklijke Philips NV

Key strategies adopted by some of these companies:

In March 2022, Trivitron Healthcare Pvt Ltd announced its acquisition of The Kennedy Company, a manufacturer of Acoustic Barrier and X-ray Shielding Material Products, to enhance its manufacturing presence in the US.

In July 2022, with its compact design and superior image quality, even at a low dosage, Siemens Healthineers AG launched its Multix Impact E, an economical X-ray apparatus, to increase access to diagnostic care.

In April 2022, a multi-year agreement was announced between Koninklijke Philips NV and Prisma Health, a non-profit organization in South Carolina, the United States, to boost the healthcare system, achieve enterprise interconnectivity, centralize patient monitoring, and encourage innovation in enterprise imaging solutions. These goals will help improve patient care and clinical performance.

Additionally, in April 2022, Trivitron Healthcare Pvt Ltd increased its capacity for production by constructing a second ultrasound manufacturing facility in Mumbai, India. This facility will be used to produce a variety of cutting-edge ultrasound devices and accessories and lessen dependence on imports for meeting domestic needs.

Report Synopsis:

Report Scope

Details
Market Forecast Years 2022-2030
Base Year 2021
Market Historical Years 2018-2021
Forecast Units Revenue ($ Million)
Segments Analyzed Product, Type, End-user
Geographies Analyzed North America, Europe, Asia-Pacific, Rest of World
Companies Analyzed

GE Healthcare, Bracco Diagnostic Inc, Trivitron Healthcare Pvt Ltd, Koninklijke Philips NV, Daiichi Sankyo Company, Limited, Siemens Healthineers AG, Lantheus Medical Imaging, Inc, Shenzhen Mindray Bio-Medical Electronics Co Ltd, NanoPET Pharma GmbH, Bayer AG, Taejoon Pharm Co Ltd, Sanochemia Pharmazeutika GmbH

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • SURGING PREVALENCE OF CHRONIC DISEASES
      • HEALTH PRACTITIONERS PREFER CONTRAST ENHANCED ULTRASOUND IMAGING
      • TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSIS
    • KEY RESTRAINTS
      • NON-UNIFORMITY OF CONTRAST AGENTS
      • DIFFICULTY IN ADOPTION IN THE CURRENT HEALTHCARE SYSTEM
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON CONTRAST ENHANCED ULTRASOUND MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
      • COST EFFICIENCY
      • PRODUCT FEATURES
      • END-USE
    • REGULATORY FRAMEWORK
  2. MARKET BY PRODUCT
    • EQUIPMENT
    • CONTRAST AGENT
  3. MARKET BY TYPE
    • NON-TARGETED
    • TARGETED
  4. MARKET BY END-USER
    • HOSPITALS
    • CLINICS
    • AMBULATORY DIAGNOSTIC CENTERS
  5. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • SPAIN
        • NORDIC COUNTRIES
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • TAIWAN
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • MERGERS & ACQUISITIONS
      • PRODUCT LAUNCHES & DEVELOPMENTS
      • PARTNERSHIPS & AGREEMENTS
      • BUSINESS EXPANSIONS & DIVESTITURES
    • COMPANY PROFILES
      • BAYER AG
      • BRACCO DIAGNOSTIC INC
      • DAIICHI SANKYO COMPANY LIMITED
      • GE HEALTHCARE
      • KONINKLIJKE PHILIPS NV
      • LANTHEUS MEDICAL IMAGING INC
      • NANOPET PHARMA GMBH
      • SANOCHEMIA PHARMAZEUTIKA GMBH
      • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO LTD
      • SIEMENS HEALTHINEERS AG
      • TAEJOON PHARM
      • TRIVITRON HEALTHCARE

LIST OF TABLES  

TABLE 1: GLOBAL MARKET SNAPSHOT – CONTRAST ENHANCED ULTRASOUND

TABLE 2: EXAMPLES OF CURRENT CLINICAL ULTRASOUND CONTRAST AGENTS

TABLE 3: EXAMPLES OF EMERGING ULTRASOUND MICROBUBBLES-BASED TECHNIQUES

TABLE 4: REGULATORY FRAMEWORK

TABLE 5: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 6: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 7: GLOBAL EQUIPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 8: GLOBAL EQUIPMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 9: GLOBAL CONTRAST AGENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 10: GLOBAL CONTRAST AGENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 11: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 12: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 13: GLOBAL NON-TARGETED MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 14: GLOBAL NON-TARGETED MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 15: GLOBAL TARGETED MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 16: GLOBAL TARGETED MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 17: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 18: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 19: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 20: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 21: GLOBAL CLINICS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 22: GLOBAL CLINICS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 23: GLOBAL AMBULATORY DIAGNOSTIC CENTERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 24: GLOBAL AMBULATORY DIAGNOSTIC CENTERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 25: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 26: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 27: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 28: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 29: LEADING PLAYERS OPERATING IN NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET

TABLE 30: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 31: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 32: LEADING PLAYERS OPERATING IN EUROPE CONTRAST ENHANCED ULTRASOUND MARKET

TABLE 33: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 34: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 35: LEADING PLAYERS OPERATING IN ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET

TABLE 36: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 37: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 38: LEADING PLAYERS OPERATING IN REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET

TABLE 39: LIST OF MERGERS & ACQUISITIONS

TABLE 40: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 41: LIST OF PARTNERSHIPS & AGREEMENTS

TABLE 42: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE

FIGURE 5: VALUE CHAIN ANALYSIS

FIGURE 6: KEY BUYING CRITERIA

FIGURE 7: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

FIGURE 8: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY EQUIPMENT, 2022-2030 (IN $ MILLION)

FIGURE 9: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY CONTRAST AGENT, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY TYPE, IN 2021

FIGURE 11: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY NON-TARGETED, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY TARGETED, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021

FIGURE 14: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY HOSPITALS, 2022-2030 (IN $ MILLION)

FIGURE 15: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY CLINICS, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL CONTRAST ENHANCED ULTRASOUND MARKET, BY AMBULATORY DIAGNOSTIC CENTERS, 2022-2030 (IN $ MILLION)

FIGURE 17: NORTH AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 18: UNITED STATES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 19: CANADA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 20: EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 21: UNITED KINGDOM CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 22: GERMANY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 23: FRANCE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 24: ITALY CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 25: SPAIN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 26: NORDIC COUNTRIES CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 27: REST OF EUROPE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 28: ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)

FIGURE 29: CHINA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 30: JAPAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 31: INDIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 32: SOUTH KOREA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 33: INDONESIA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 34: SINGAPORE CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 35: TAIWAN CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 36: AUSTRALIA & NEW ZEALAND CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 37: REST OF ASIA-PACIFIC CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 38: REST OF WORLD CONTRAST ENHANCED ULTRASOUND MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 39: LATIN AMERICA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

FIGURE 40: MIDDLE EAST & AFRICA CONTRAST ENHANCED ULTRASOUND MARKET, 2022-2030 (IN $ MILLION)

  1. MARKET BY PRODUCT
    • EQUIPMENT
    • CONTRAST AGENT
  2. MARKET BY TYPE
    • NON-TARGETED
    • TARGETED
  3. MARKET BY END-USER
    • HOSPITALS
    • CLINICS
    • AMBULATORY DIAGNOSTIC CENTERS
  4. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • SPAIN
        • NORDIC COUNTRIES
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • SOUTH KOREA
        • INDONESIA
        • SINGAPORE
        • TAIWAN
        • AUSTRALIA & NEW ZEALAND
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


    Frequently Asked Questions (FAQs):

    Which country has the highest growth potential in the Asia-Pacific contrast enhanced ultrasound market?

    South Korea has the highest growth potential in the Asia-Pacific contrast enhanced ultrasound market.

    Which segments are projected to drive the most demand for contrast enhanced ultrasound?

    Targeted ultrasound and contrast agents are projected to drive the most demand for contrast enhanced ultrasound.

    Which is a notable trend in the global contrast enhanced ultrasound market?

    The increasing collaboration among Asian governments, international development organizations, and healthcare firms, is a notable trend in the global contrast enhanced ultrasound market.

    To request a free sample copy of this report, please complete the form below:

    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.


      Choose License Type